Wcn24-1473 Initial Response to Prednisone as a Predictor of Renal Survival in Patients With Nephrotic Syndrome and Primary Focal Segmental Glomerulosclerosis

Focal segmental glomerulosclerosis (FSGS) is the most frequent primary glomerulopathy in México and the one that most frequently progresses to chronic kidney disease, with a 10-year global renal survival of 50%. Therefore, it is important to identify the factors that predict the progression of renal disease. The first line of treatment recommended in the KDIGO guidelines is prednisone with which partial remission + complete remission of proteinuria is achieved in 50-64% of patients. However, little is known about the significance of the initial response to prednisone in the progression of renal disease.